Back

Genomic Epidemiology of the 2025 Guangdong CHIKV Outbreak-Implication for CHIKV intervention

Yi, L.; xiang, s.; Huang, X.; Huang, J.; Chen, M.; Long, H.; He, Y.; Zeng, C.; Zhu, G.; Tan, S.; Peng, X.; Liu, Z.; Gao, S.; Lu, J.

2026-06-26 epidemiology
10.64898/2026.06.16.26355213 medRxiv
Show abstract

Chikungunya virus (CHIKV) causes recurrent epidemics across tropical and subtropical regions globally. In 2025, Guangdong reported mainland China's largest documented CHIKV outbreak, with 23,464 cases across all 21 prefecture-level cities. Integrating epidemiological, genomic, and phylodynamic analyses, we investigated the outbreak's origins, transmission, and viral adaptation. The Guangdong strain belonged to the ECSA-MAL lineage, exhibiting a long internal branch that highlights significant global surveillance gaps. Phylodynamic modeling estimated viral introduction in early April 2025, revealing ~2.5 months of cryptic transmission alongside rising vector densities. Spatial case distribution was moderately associated with human mobility from the epicenters. Globally, phylogenetic analysis identified 33 potential adaptive mutations across nine proteins and 14 epidemic lineages, including validated and 15 novel mutations. Twelve novel mutations occurred in the Asian Urban lineage (AUL), predominantly affecting NSP3. This study underscores the need for enhanced pre-peak surveillance and continuous monitoring of viral adaptation across ecological regions.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 10%
18.0%
2
Virus Evolution
155 papers in training set
Top 0.2%
10.7%
3
The Lancet Infectious Diseases
73 papers in training set
Top 0.1%
7.7%
4
Emerging Microbes & Infections
74 papers in training set
Top 0.2%
5.3%
5
The Journal of Infectious Diseases
202 papers in training set
Top 0.7%
5.0%
6
Science China Life Sciences
29 papers in training set
Top 0.1%
4.2%
50% of probability mass above
7
Nature Medicine
125 papers in training set
Top 0.8%
3.1%
8
eBioMedicine
183 papers in training set
Top 1%
3.1%
9
Science Advances
1243 papers in training set
Top 13%
2.7%
10
Communications Medicine
113 papers in training set
Top 1%
2.4%
11
Emerging Infectious Diseases
105 papers in training set
Top 0.6%
2.4%
12
Viruses
332 papers in training set
Top 2%
2.3%
13
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 29%
1.7%
14
PLOS Neglected Tropical Diseases
466 papers in training set
Top 4%
1.7%
15
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.1%
1.7%
16
Cell Reports
1498 papers in training set
Top 21%
1.5%
17
eLife
5828 papers in training set
Top 55%
1.3%
18
Journal of Infection
78 papers in training set
Top 1.0%
1.1%
19
PLOS Pathogens
820 papers in training set
Top 8%
1.1%
20
Cell Discovery
57 papers in training set
Top 0.9%
1.0%
21
Influenza and Other Respiratory Viruses
46 papers in training set
Top 0.6%
1.0%
22
Microbial Genomics
225 papers in training set
Top 2%
1.0%
23
Communications Biology
993 papers in training set
Top 26%
1.0%
24
Journal of Medical Virology
140 papers in training set
Top 3%
0.8%
25
PLOS Medicine
110 papers in training set
Top 4%
0.8%
26
Science Translational Medicine
127 papers in training set
Top 4%
0.8%
27
Scientific Reports
3612 papers in training set
Top 76%
0.8%
28
EMBO Molecular Medicine
95 papers in training set
Top 3%
0.8%
29
PLOS Biology
486 papers in training set
Top 13%
0.8%
30
Eurosurveillance
83 papers in training set
Top 1%
0.6%